Northwestern University and Deerfield Management launched Lakeside Discovery, LLC, formally announced the partnership which will provide up to $65 million of targeted funding and deep development expertise to advance promising Northwestern research.
Browsing: Research
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, according to a study published in PLOS Medicine.
Triclosan, a common antimicrobial used in toothpastes and other products, may raise the risk of gut inflammation and colorectal cancer, according to a preliminary animal study.
A team of scientists has identified a key enhancer of Sox9 — a gene critical for male sex development — and demonstrated that deleting the enhancer results in male-to-female sex reversal in animal models.
A new device called a regenerative bandage, developed by Northwestern scientists, quickly heals hard-to-treat diabetic wounds and sores without using drugs.
Laws banning smoking at workplaces and other public places are associated with a significantly lower risk of cardiovascular disease, according to a new study.
Lack of a receptor regulating mitochondrial metabolism was linked with kidney dysfunction including kidney disease, according to a recent study.
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
Along with Deerfield Management, Northwestern has announced a $65 million investment and the launch of Lakeside Discovery, LLC, with the mission to accelerate the translation of transformative biomedical technologies.
Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.